Literature DB >> 29279004

Insights into the role of ribonuclease 4 polymorphisms in amyotrophic lateral sclerosis.

Aditya K Padhi1, Priyam Narain1, Upma Dave1, Rohit Satija1, Anirudh Patir1, James Gomes1.   

Abstract

Mutations in certain genes of the Ribonuclease (RNASE) superfamily can cause amyotrophic lateral sclerosis (ALS) through altered RNA processing mechanisms. About 30 of these missense mutations in RNASE5/ANG gene have already been reported in ALS patients. In another gene of the ribonuclease superfamily, ribonuclease 4 (RNASE4), missense mutations and single nucleotide polymorphisms have been identified in patients suffering from ALS. However, their plausible molecular mechanisms of association with ALS are not known. Here, we present the molecular mechanisms of RNASE4 polymorphisms with ALS using all-atom molecular dynamics (MD) simulations followed by functional assay experiments. As most ALS causing mutations in RNASE superfamily proteins affect either the ribonucleolytic or nuclear translocation activity, we examined these functional properties of wild-type and known RNASE4 variants, R10W, A98V, E48D and V75I, using MD simulations. Our simulation predicted that these variants would retain nuclear translocation activity and that E48D would exhibit loss of ribonucleolytic activity, which was subsequently validated by ribonucleolytic assay. Our results give a mechanistic insight into the association of RNASE4 polymorphisms with ALS and show that E48D-RNASE4 would probably be deleterious and cause ALS in individuals harbouring this polymorphism.

Entities:  

Keywords:  ALS: amyotrophic lateral sclerosis; CD: circular dichroism; DAPI: 4′,6-diamidino-2-phenylindole (DAPI) dihydrochloride; FBS: foetal bovine serum; GST: glutathione S-transferase; HEPES: 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid; IPTG: isopropyl β-D-1-thiogalactopyranoside; MD: molecular dynamics; Ni-NTA: Ni-nitrilotriacetic acid; OD: optical density; PBS: phosphate buffered saline; RMSD: root mean square deviation; RNA processing pathway; RNASE4: ribonuclease 4; SDS-PAGE: sodium dodecyl sulphate-polyacrylamide gel electrophoresis; TIP3P: three-point transferable intermolecular potential; VMD: visual molecular dynamics; amyotrophic lateral sclerosis; loss-of-functions; molecular dynamics; polymorphism; ribonuclease 4; tRNA: transfer RNA

Mesh:

Substances:

Year:  2018        PMID: 29279004     DOI: 10.1080/07391102.2017.1419147

Source DB:  PubMed          Journal:  J Biomol Struct Dyn        ISSN: 0739-1102


  6 in total

1.  Rare Angiogenin and Ribonuclease 4 variants associated with amyotrophic lateral sclerosis exhibit loss-of-function: a comprehensive in silico study.

Authors:  Aditya K Padhi; Priyam Narain; James Gomes
Journal:  Metab Brain Dis       Date:  2019-07-31       Impact factor: 3.584

2.  Identification and characterization of novel and rare susceptible variants in Indian amyotrophic lateral sclerosis patients.

Authors:  Priyam Narain; Aditya K Padhi; Upma Dave; Dibyakanti Mishra; Rohit Bhatia; Perumal Vivekanandan; James Gomes
Journal:  Neurogenetics       Date:  2019-08-20       Impact factor: 2.660

3.  Expression and function of human ribonuclease 4 in the kidney and urinary tract.

Authors:  Kristin Bender; Laura L Schwartz; Ariel Cohen; Claudia Mosquera Vasquez; Matthew J Murtha; Tad Eichler; Jason P Thomas; Ashley Jackson; John David Spencer
Journal:  Am J Physiol Renal Physiol       Date:  2021-04-05

Review 4.  The Immunomodulatory and Antimicrobial Properties of the Vertebrate Ribonuclease A Superfamily.

Authors:  Laura Schwartz; Ariel Cohen; Jason Thomas; John David Spencer
Journal:  Vaccines (Basel)       Date:  2018-11-20

Review 5.  Biological Activities of Secretory RNases: Focus on Their Oligomerization to Design Antitumor Drugs.

Authors:  Giovanni Gotte; Marta Menegazzi
Journal:  Front Immunol       Date:  2019-11-26       Impact factor: 7.561

6.  The Anti-Apoptotic Effect of ASC-Exosomes in an In Vitro ALS Model and Their Proteomic Analysis.

Authors:  Roberta Bonafede; Jessica Brandi; Marcello Manfredi; Ilaria Scambi; Lorenzo Schiaffino; Flavia Merigo; Ermanna Turano; Bruno Bonetti; Emilio Marengo; Daniela Cecconi; Raffaella Mariotti
Journal:  Cells       Date:  2019-09-14       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.